Researchers discover lysin able to kill multidrug-resistant bacteria

February 17, 2022

Researchers from the Antimicrobial Resistance (AMR) Interdisciplinary Research Group (IRG) at Singapore-MIT Alliance for Research and Technology (SMART), MIT’s research enterprise in Singapore, alongside collaborators at Nanyang Technological University, have identified a novel phage lysin – Abp013 – that could be used as an alternative antimicrobial agent against two of the most deadly bacteria: Acinetobacter baumannii and Klebsiella pneumoniae.

Health Care Asia Home Health Care Asia-
Researchers discover lysin able to kill multidrug-resistant bacteria

Researchers from the Antimicrobial Resistance (AMR) Interdisciplinary Research Group (IRG) at Singapore-MIT Alliance for Research and Technology (SMART), MIT’s research enterprise in Singapore, alongside collaborators at Nanyang Technological University, have identified a novel phage lysin – Abp013 – that could be used as an alternative antimicrobial agent against two of the most deadly bacteria: Acinetobacter baumannii and Klebsiella pneumoniae. The study is supported by the National Research Foundation (NRF) Singapore, under its Intra-CREATE Collaborative Seed Grant.

Lysins – enzymes produced by bacteriophages – have displayed great potential as a novel class of antimicrobials as their properties allow them to quickly and directly target key structural components of a bacteria’s cell walls, and in doing so, reduce the bacteria’s ability to develop resistance. 

The inappropriate and extensive use of antibiotics over the past few decades have led to the emergence of antimicrobial resistance – a phenomenon in which bacterial strains develop mechanisms to resist medicines designed to kill them. In 2019 alone, it is estimated that 4.95 million people died from infections either associated with or attributable to antimicrobial resistance. This already pressing issue, compounded further by the widespread usage of antibiotics during the COVID-19 pandemic, highlights the urgent need for new therapeutic agents that are difficult for bacteria to develop resistance against. 

“Antimicrobial resistance remains an ever-growing threat to humankind, and an increasing number of people die each year from superbug infections. The development of new bacteria-killing agents is crucial, and lysins have shown great promise in treating deadly chronic wound and lung infections against which no antibiotics are effective and limited treatment options are available,” said Joash Chu, first author of the paper that documented the discovery, and former researcher at SMART at the time of the study.

Lysins have been highly effective in fighting Gram-positive bacteria – which do not have an outer lipid membrane and thus easily killed by lysins. Conversely, in Gram-negative bacteria, the presence of an outer membrane impedes many lysins from killing the bacteria efficiently. Hence, the discovery of novel lysin Abp013 is crucial in the advancement of treatment methods against multidrug-resistant Gram-negative pathogens. 

In a paper titled “Novel Phage Lysin Abp013 against Acinetobacter baumannii” published in medical journal Antibiotics, the SMART AMR team reveals their findings on Abp013’s ability to effectively access and kill various bacterial strains. The study showed that Abp013 displayed good permeability and killing activity against multiple Acinetobacter baumannii and Klebsiella pneumoniae strains, even when they are in a more complex environment in which typical lysins are ineffective. 

Acinetobacter baumannii and Klebsiella pneumoniae are superbugs responsible for a multitude of potentially life-threatening infections, such as pneumonia and meningitis, especially among the ill and immunocompromised. Unfortunately, many strains of these bacteria are difficult to treat as they grow increasingly resistant to antibiotics. Typically, to treat Acinetobacter infections, healthcare providers have to send a specimen for laboratory testing to determine which antibiotics are effective in fighting the bacteria. Thus, the important discovery of Abp013 and its unique bacteria-targeting properties could advance the development of remedies for quicker and more effective targeting of these bacteria. 

“Abp013 is the first Gram-negative lysin found to display host selectivity. Prior to the discovery of Abp013, no other lysins are capable of targeting Acinetobacter baumannii and Klebsiella pneumoniae but not Pseudomonas aeruginosa. Understanding the mechanism behind such selectivity will help guide the development of lysin variants customised to only target pathogenic bacteria, for more precise treatment of bacterial infections,” said Dr Goh Boon Chong, Principal Research Scientist at SMART AMR, and a co-corresponding author of the paper.

Moving forward, the researchers will further investigate the crystal structure of this novel lysin and understand its unique underlying mechanisms. These will open the possibility of swapping or merging the lysin’s components with other lysins or antimicrobial components to spur the engineering of Gram-negative lysins with superior potency, and lead to the development of alternative therapeutic agents that can resist the resistance. 

SMART AMR has been developing methods for the customised targeting of bacteria using lysins, and these endeavours were nurtured by the early support of the SMART Innovation Centre. National Research Foundation (NRF) Singapore’s Intra-CREATE Collaborative Seed Grant encourages and facilitates collaboration between CREATE’s Partner Institutions co-located in Singapore, to achieve greater impact from collaborative research efforts.

Tags: ,

Category: Education, Features

Comments are closed.

Subscribe to HCA for exclusive updates

Top Viewed News

12 simple steps to a healthy lifestyle

12 simple steps to a healthy lifestyle

Now that the world has returned to normalcy following the pandemic, everyone is back to their daily routines and encounters with stress... Read More

AZBIL: Envisioning the Future of Hospitals

AZBIL: Envisioning the Future of Hospitals

As we strive to be the hospital of choice, why not refine our commitment to excellence beyond the pivotal mission of saving lives?... Read More

Study Unlocks Key Findings on Asian Carriers of Breast Cancer

Study Unlocks Key Findings on Asian Carriers of Breast Cancer

Malaysian researchers at Cancer Research Malaysia (CRMY) and the University of Nottingham Malaysia (UNM) have published... Read More

 Unmasking the Risks of Mercury-Laden Cosmetics

Unmasking the Risks of Mercury-Laden Cosmetics

As the saying goes, beauty is in the eye of the beholder and thus subjective; but in some countries, the ideal of beauty begins... Read More

5 key hospital etiquettes to be mindful of when visiting a sick patient

5 key hospital etiquettes to be mindful of when visiting a sick patient

In moments of illness, the presence of loved ones can comfort and support. However, it’s important for visitors... Read More

Free counters!

2025 – 2026 Exhibitions



2025 Events


9-11 July
Medical Device Development (MEDIX) – Osaka
Makuhari Messe, Japan
www.manufacturing-world.jp


14-16 July
Lab Asia
Kuala Lumpur Convention Centre (KLCC), Malaysia
www.lab-asia.com


16-18 July
Medlab Asia | Asia Health
Malaysia International Trade & Exhibition Centre, Kuala Lumpur
www.medlabasia.com


24 July
Medlab Asia | Asia Health
Singapore
www.conversationaltechsummitasia.com


13-15 August
Philippines Medical
SMX Convention Center Manila Philippines
www.philmedical.com


21-23 August
REHACARE China
Suzhou, China
www.rehacare-c.com


21-23 August
Medical Fair China
Suzhou, China
www.medicalfair.cn


3-5 September
Thailand Lab International
BITEC, Bangkok, Thailand
www.thailandlab.com


3-5 September
Bio Ap International
BITEC, Bangkok
www.bioapinter.com


9-12 September
China Dental Show
National Exhibition and Convention Center (Shanghai)
www.chinadentalshow.com


10-11 September
Hospital Management Asia
Shangri-La Kuala Lumpur, Malaysia
www.hospitalmanagementasia.com


10-12 September
Medical Fair Thailand
BITEC, Bangkok
www.medicalfair-thailand.com


10-12 September
GITEX Digi Health & Biotech Thailand
BITEC, Bangkok
www.www.gitexdigihealth.com


11-13 September
Bio Asia Pacific
BITEC, Bangkok
www.bioasiapacific.com


16-18 September
OSH India
Hall-6, Bombay Exhibition Centre, Goregaon (E)
www.oshindia.com


24-26 September
Medtec China
Shanghai, China
www.en.medtecchina.com


7-9 October
Malaysia Pharma and Healthcare Expo
Kuala Lumpur, Malaysia
www.mphcexpo.com


9-11 October
Medical Japan Tokyo
Makuhari Messe, Japan
www.medical-jpn.jp


17-19 October
Health Asia
BITEC, Bangkok
www.health-asia.com


17-19 October
Health Asia
BITEC, Bangkok
www.health-asia.com


29-30 October
United Medical Expo
Astana, Kazakhstan
www.umtexpo.com


7-8 November
Eldercare Exhibition and Conference Asia (ELDEX Asia)
Suntex Singapore Exhibition and Convention Centre
www.eldexasia.com


10-12 November
Saudi International Pharma Expo
Riyadh International Convention and Exhibition Center
www.saudipharmaexpo.com


10-12 November
Saudi International MedLab Expo
Riyadh International Convention and Exhibition Center
www.saudimedlabexpo.com


27-29 November
International Wellness Expo (IWE 2025)
METIC, Malaysia
www.internationalwellnessexpo.com


27-29 November
Vietnam Medi-Pharm
Friendship Cultural Palace , Hanoi
www.vietnammedipharm.vn


2026 Events


9-12 Febuary
Arab Health
Dubai World Trade Centre
www.arabhealthonline.com


15-17 April
Lab Indonesia
Jakarta Convention Center, Jakarta, Indonesia
www.lab-indo.com


28-30 April
SEACare
MITEC, KL
wwww.ea-healthcare.com


6-7 May
HealthTechX Asia
Sands Expo & Convention Centre, Singapore
www.healthtechx-asia.com


4-6 June
International Health Industry Expo
China
www.ihe-china.com


16-18 June
CPhI China
SNIEC, Shanghai, China
www.cphi.com


25-27 June
Medical Taiwan
Taipei Nangang Exhibition Center, Taipei, Taiwan
www.medicaltaiwan.com.tw


9-11 September
Medical Fair Asia
Marina Bay Sands, Singapore
www.medicalfair-asia.com


9-11 September
Medical Manufacturing Asia
Marina Bay Sands, Singapore
www.medmanufacturing-asia.com


1-2 October
GITEX Vietnam
Hanoi
www.gitexasia.com